Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia

BMJ Case Rep. 2014 Apr 15:2014:bcr2014204477. doi: 10.1136/bcr-2014-204477.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Dasatinib
  • Female
  • Humans
  • Hypertension, Pulmonary / chemically induced*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*
  • Thiazoles / adverse effects*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib